Hagens Berman & Patrick Soon-Shiong
2 shared events · Importance 4 · Last updated May 06, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Regulatory
Hagens Berman: Hagens Berman is a national shareholders rights firm investigating claims that ImmunityBio violated federal securities laws and is urging investors to submit their losses.
Patrick Soon-Shiong: Patrick Soon-Shiong, executive chairman and Chief Scientific and Medical Officer of ImmunityBio, is accused of materially overstating Anktiva's capabilities, leading to the lawsuit.
Apr 02, 2026 · 42 articles
NEWSDESK
Explore this relationship live
Track how Hagens Berman and Patrick Soon-Shiong interact across events, view sentiment trends, and discover connected entities.
Open Dashboard